Topics

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

A cohort study investigates the magnitude of lost coverage among pediatric patients, following the conclusion of the pandemic public health emergency.

Investigating the Unwinding of Continuous Medicaid Coverage During the COVID-19 Pandemic

New engagement approaches can help drive treatment gains in underrepresented communities.


Closing the Health Literacy and Diversity Gaps in Clinical Trials

A survey study of US employers aims to determine whether they prioritize financial or nonfinancial criteria when selecting health plans.

A Further Exploration of Employer Benefits

A founding partner with Curatio Scientia Advisors.

A founding partner with Curatio Scientia Advisor.

A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.

Transforming Specialty Pharmacy Engagement

Can monitoring these dispensed Rxs via online search behavior help predict future GLP-1 use in the United States?

Determining the Correlation Between Obesity Management Drug Dispensed Prescriptions and Online Search Behavior

A study explores dual-enrollment in these plans—compared to other Medicare Advantage plans— impacts North Carolina’s Medicaid fee-for-service spending.

How Dual-Eligible Special Needs Plans Affect Medicaid Spending

The investment not only moves along the company’s efforts in advancing clinical studies, but also opens up 700 new jobs for the Greater Toronto area. 

AstraZeneca to Financially Commit $570M Toward Global Hub Expansion in Canada

Videos

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, describes the importance of the patient within the pharma supply chain.

Focusing on the Patient

The latest AARP report concludes that plan members who hit this amount are expected to see savings, even when premiums are considered. 

Analysis: Medicare Part D Enrollees Who Reach the $2,000 OOP Spending Cap to Save an Average of $2,474 Nationally 

In the fourth part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, discusses the origins of the compounding pharmacy, including what it seeks to accomplish.  

Patient Support